BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 6288105)

  • 21. Cyclic nucleotide phosphodiesterases in glomeruli of rat renal cortex.
    Torres VE; Hui YS; Shah SV; Northrup TE; Dousa TP
    Kidney Int; 1978 Nov; 14(5):444-51. PubMed ID: 220459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities.
    Lugnier C; Gauthier C; Le Bec A; Soustre H
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H654-60. PubMed ID: 1373036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of regucalcin on Ca2+/calmodulin-dependent cyclic AMP phosphodiesterase activity in rat kidney cytosol.
    Yamaguchi M; Kurota H
    Mol Cell Biochem; 1997 Dec; 177(1-2):209-14. PubMed ID: 9450664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide.
    Bellamy TC; Garthwaite J
    Mol Pharmacol; 2001 Jan; 59(1):54-61. PubMed ID: 11125024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
    Murray F; MacLean MR; Pyne NJ
    Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calmodulin-stimulated cyclic nucleotide phosphodiesterases in plasma membranes of bovine epididymal spermatozoa.
    Chaudhry PS; Casillas ER
    Arch Biochem Biophys; 1988 May; 262(2):439-44. PubMed ID: 2835007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
    Souness JE; Diocee BK; Martin W; Moodie SA
    Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ca2+-calmodulin-activated cyclic nucleotide phosphodiesterase from the rabbit myometrium].
    Osipenko AA; Prishchepa LA; Kurskiĭ MD
    Ukr Biokhim Zh (1978); 1986; 58(4):26-31. PubMed ID: 3016961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concanavalin A stimulates the Rolipram-sensitive isoforms of cyclic nucleotide phosphodiesterase in rat thymic lymphocytes.
    Valette L; Prigent AF; Némoz G; Anker G; Macovschi O; Lagarde M
    Biochem Biophys Res Commun; 1990 Jun; 169(3):864-72. PubMed ID: 2163636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificity of cGMP binding to a purified cGMP-stimulated phosphodiesterase from bovine adrenal tissue.
    Miot F; Van Haastert PJ; Erneux C
    Eur J Biochem; 1985 May; 149(1):59-65. PubMed ID: 2581780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calmodulin-stimulated cyclic nucleotide phosphodiesterase from Neurospora crassa.
    Ortega Perez R; Van Tuinen D; Marmé D; Turian G
    Biochim Biophys Acta; 1983 Jul; 758(1):84-7. PubMed ID: 6305427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic GMP-dependent stimulation of the membrane-bound insulin-sensitive cAMP phosphodiesterase from rat adipocytes.
    Robinson FW; Smith CJ; Flanagan JE; Shibata H; Kono T
    J Biol Chem; 1989 Oct; 264(28):16458-64. PubMed ID: 2550445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
    Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
    Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic nucleotide phosphodiesterases in cultured normal and RCS rat pigment epithelium: kinetics of cyclic AMP and cyclic GMP hydrolysis.
    Kurtz MJ; Edwards RB; Schmidt SY
    Exp Eye Res; 1987 Jul; 45(1):67-75. PubMed ID: 2820772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic 3',5'-nucleotide phosphodiesterase activities in the thyroid glands of patients with various disorders.
    Nagasaka A; Hidaka H
    J Clin Endocrinol Metab; 1980 Apr; 50(4):726-33. PubMed ID: 6245100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. cGMP-phosphodiesterase antagonists inhibit Ca2+-influx in Dictyostelium discoideum and bovine cyclic-nucleotide-gated-channel.
    Lusche DF; Kaneko H; Malchow D
    Eur J Pharmacol; 2005 Apr; 513(1-2):9-20. PubMed ID: 15878705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of soluble uterine cyclic nucleotide phosphodiesterase.
    Gardner EA; Thompson WJ; Strada SJ; Stancel GM
    Biochemistry; 1978 Jul; 17(15):2995-3000. PubMed ID: 212098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Properties of cyclic nucleotide phosphodiesterase from lingual taste papillae].
    Ostretsova IB
    Biokhimiia; 1978 Jun; 43(6):1037-44. PubMed ID: 27246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of rat cerebral cortical 3',5'-cyclic nucleotide phosphodiesterase activity by gangliosides.
    Davis CW; Daly JW
    Mol Pharmacol; 1980 Mar; 17(2):206-11. PubMed ID: 6248757
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.